Key facts
- Microneedle Solutions’s last known valuation is $6.8M (Dec 2025).
- It has raised $2.5M; the latest was Seed Round ($2.1M) in Dec 2025.
- Notable investors include SFC Capital, Cambridge Angels, Pioneer Group, Science Entrepreneur Club, Sheffield Angels — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Microneedle Solutions
- ·The full record, as it builds
Funding rounds
No funding rounds for Microneedle Solutions are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Microneedle Solutions
Developer of microneedle-based medical patch designed for vaccine and drug delivery. The company produces self-adhesive vaccine microneedle patches utilizing solid silica or metal-based microscopic structures pre-coated with active pharmaceutical ingredients, which penetrate the outermost layer of the skin to facilitate transdermal delivery, providing healthcare professionals with a convenient and less invasive alternative to traditional injections.
- Sector
- Healthcare
- HQ
- Leeds, United Kingdom
- Founded
- 2022
- Employees
- 7
- Website
- microneedlesolutions.com/
- Ownership
- Privately Held (backing)
Microneedle Solutions doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Microneedle Solutions shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Microneedle Solutions in its N-PORT filings yet. We sweep new filings monthly.